The Kidney Protocol: 51 Critical Questions to Demand Transparency From Your Kidney Care Team

Most kidney patients leave their appointments with the same two things they walked in with: vague reassurance and no written plan. The numbers were mentioned but not explained. The trend was described as stable but never quantified. The medication list was glanced at but not reconciled. The referral that should have happened six months ago was deferred again without a stated reason. And the patient — who came prepared to fight for their life — left without the specific, direct, documented answers that fighting requires.

This is not an accident. It is the texture of how American nephrology operates. The system has never required that kidney patients be fully informed, and most clinicians have never been trained to ensure they are. The result is a population of patients who arrive at dialysis without working vascular access, who learn about transplant a year too late, who are on medication regimens that were appropriate at a higher eGFR and have never been reviewed since, and whose blood pressure is being managed off office readings that diverge from home readings by twenty points.

The Kidney Protocol exists to break that pattern.

This is 51 clinically grounded, federally informed, plainly written questions organized across four sections — pathology and progression, medication and toxicity, nutrition and metabolic control, and strategy and liberation. Each question is paired with a direct explanation of why it matters: the specific physiological mechanism, the evidence base, the gap it exposes, and what a complete answer looks like versus what a deflection sounds like. These are not general conversation starters. They are precision instruments designed to move a clinical encounter from passive information delivery to active accountability — and to give the patient a written, documented record of what was said, what was committed to, and what was left unanswered.

Section one covers the numbers your team should be tracking and the trends that reveal more than any single visit: your eGFR trajectory, your proteinuria trend, your full KDIGO staging across both axes, your Kidney Failure Risk Equation score at two and five years, and the monitoring thresholds that should trigger action before crisis arrives.

Section two covers your medication list with the specificity it deserves: whether doses have been adjusted for your current kidney function, whether you are on the evidence-based agents your situation calls for — including SGLT2 inhibitors and finerenone — which drugs on your list carry nephrotoxic risk, and who across your entire prescribing team is actually checking for interactions.

Section three covers the nutritional levers that protect or accelerate kidney decline every single day: your individualized targets for protein, sodium, potassium, and phosphorus — not generic numbers but numbers tied to your labs, your stage, and your clinical situation — along with questions that expose whether you have ever actually been referred to a registered dietitian trained in kidney disease, which Medicare covers for many CKD patients as a Part B benefit.

Section four covers trajectory and strategy: when you will need dialysis or transplant if the current trend continues, whether you have been referred for transplant evaluation, whether preemptive transplant has ever been discussed, what your vascular access plan is and when it will be placed, whether multiple listing could shorten your wait, how to have the DCD and higher-KDPI donor conversation before the organ offer call arrives, and — most importantly — whether the plan discussed today will be put in writing, signed, and sent through the patient portal before you leave.

The protocol closes with the single most structurally important question in the entire document: will you put the plan in writing? A verbal plan is not a plan. A written, dated, signed plan is. That one request, made consistently, changes the quality of every visit that follows.

This guide was written by Jeff A. Parke — Founder of Cold Ischemia Foundation, three-time kidney transplant recipient, and a professional with nineteen years of pharmaceutical clinical development experience and Lean Six Sigma credentials — and published by an organization that accepts zero pharmaceutical funding, zero dialysis industry support, and zero sponsored content of any kind. No one paid to soften what is in these pages. Every dollar of revenue returns directly to CIF's mission of building structural advocacy for the people the system never counted.

Use three to five questions per visit. Document the answers. Watch the patterns. The protocol works because you do.